<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01945216</url>
  </required_header>
  <id_info>
    <org_study_id>121-011</org_study_id>
    <secondary_id>JapicCTI-132250</secondary_id>
    <secondary_id>JapicCTI-R171018</secondary_id>
    <nct_id>NCT01945216</nct_id>
  </id_info>
  <brief_title>Alogliptin Tablets Special Drug Use Surveillance &quot;Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI&quot;</brief_title>
  <official_title>Alogliptin Tablets Special Drug Use Surveillance &quot;Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Takeda</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Takeda</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the safety and efficacy of long-term treatment with
      alogliptin (Nesina) in patients with type 2 diabetes mellitus who responded inadequately to
      diet therapy and exercise therapy alone, or a combination of diet therapy, exercise therapy,
      and α-glucosidase inhibitor.

      In addition, examining the safety and efficacy of alogliptin in patients with renal
      impairment, information on the appropriate dosage of alogliptin according to the severity of
      impaired renal function should be collected.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A special drug use surveillance is planned to examine the safety and efficacy of long-term
      use of alogliptin in patients with type 2 diabetes mellitus under the daily clinical use
      conditions.

      Participants of this surveillance will be patients with type 2 diabetes mellitus who failed
      to respond adequately to diet therapy and exercise therapy alone or to a combination of diet
      therapy, exercise therapy, and α-glucosidase inhibitor. The planned sample size is 3,000
      subjects.

      The usual adult dosage for oral use is 1 alogliptin tablet (25 mg) once daily. Participants
      will receive the drug as part of routine medical care.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 8, 2010</start_date>
  <completion_date type="Actual">October 31, 2015</completion_date>
  <primary_completion_date type="Actual">October 31, 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Who Experience at Least One Adverse Events</measure>
    <time_frame>Up to Month 36</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Glycosylated Hemoglobin (HbA1c)</measure>
    <time_frame>Baseline, Months 1, 3, 6, 12, 18, 24, 30, 36 and final assessment (up to Month 36)</time_frame>
    <description>The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at month 36 relative to baseline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Fasting Blood Glucose</measure>
    <time_frame>Baseline, Months 1, 3, 6, 12, 18, 24, 30, 36 and final assessment (up to Month 36)</time_frame>
    <description>The change in the value of fasting blood glucose collected at month 36 relative to baseline.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3317</enrollment>
  <condition>Type 2 Diabetes Mellitus Who Have Been Examined at a Medical Institution</condition>
  <arm_group>
    <arm_group_label>Alogliptin 25mg, tablets, orally, once daily, up to 36 months</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alogliptin</intervention_name>
    <description>Alogliptin tablets</description>
    <arm_group_label>Alogliptin 25mg, tablets, orally, once daily, up to 36 months</arm_group_label>
    <other_name>Nesina; SYR-322</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with type 2 diabetes mellitus who have been examined at a medical institution
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with type 2 diabetes mellitus who have not adequately responded to any one of
             the following therapies:

               1. Diet therapy and exercise therapy alone

               2. In addition to diet therapy and exercise therapy, use of α-glucosidase inhibitor

        Exclusion Criteria:

          -  Patients contraindicated for Nesina

               1. Patients with severe ketosis, diabetic coma or precoma, or type 1 diabetes
                  mellitus (these patients require prompt adjustment of hyperglycemia by fluid
                  infusion and insulin, and hence use of Nesina is not appropriate.)

               2. Patients with severe infection, pre- or post-operative patients, or patients with
                  serious traumatic injury (blood glucose control by insulin injection is desirable
                  for these patients, and hence use of Nesina is not appropriate.)

               3. Patients with a history of hypersensitivity to any ingredient of Nesina
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Study Director</last_name>
    <role>Study Director</role>
    <affiliation>Takeda</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Osaka</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>September 13, 2013</study_first_submitted>
  <study_first_submitted_qc>September 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2013</study_first_posted>
  <results_first_submitted>August 2, 2017</results_first_submitted>
  <results_first_submitted_qc>November 5, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">November 8, 2018</results_first_posted>
  <last_update_submitted>November 6, 2019</last_update_submitted>
  <last_update_submitted_qc>November 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Drug therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alogliptin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Takeda makes patient-level, de-identified data sets and associated documents available for all interventional studies after applicable marketing approvals and commercial availability have been received (or program is completely terminated), an opportunity for the primary publication of the research and final report development has been allowed, and other criteria have been met as set forth in Takeda's Data Sharing Policy (see www.TakedaClinicalTrials.com for details). To obtain access, researchers must submit a legitimate academic research proposal for adjudication by an independent review panel, who will review the scientific merit of the research and the requestor's qualifications and conflict of interest that can result in potential bias. Once approved, qualified researchers who sign a data sharing agreement are provided access to these data in a secure research environment.</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants took part in the study at 608 investigative sites in Japan, from 8-July-2010 to 31-October-2015. Data reports overall population, since data not collected separately per arm as specified in protocol.</recruitment_details>
      <pre_assignment_details>Participants with type 2 diabetes mellitus who failed to respond adequately to diet and/or exercise therapy and α-glucosidase inhibitor were enrolled to receive Alogliptin as routine medical care. Treatments were not allocated at the start of the study. Thus, the Participant Flow cannot be presented &quot;per Arm&quot;.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Overall Population</title>
          <description>Alogliptin 25 milligram (mg), tablets, orally, once daily, up to 36 months along with an alpha-glucosidase inhibitor (α-GI), without an α-GI, or the other diabetic drugs from the start of administration of alogliptin and during the treatment period of alogliptin in routine medical care.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3317"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3218"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="99"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Case report forms (CRF) uncollected</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>CRF not assured by investigators</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The safety analysis set was defined as all participants who were enrolled and completed the study.</population>
      <group_list>
        <group group_id="B1">
          <title>Alogliptin</title>
          <description>Alogliptin 25 mg, tablets, orally, once daily for up to 36 months in routine medical care. Participants in this group received no diabetic drugs within 3 months from the start of administration of alogliptin and during the treatment period of alogliptin.</description>
        </group>
        <group group_id="B2">
          <title>Alogliptin + αGI</title>
          <description>Alogliptin 25 mg, tablets, orally, once daily for up to 36 months in routine medical care. Participants in this group received an α-GI within 3 months from the start of administration of alogliptin and during the treatment period of alogliptin.</description>
        </group>
        <group group_id="B3">
          <title>Alogliptin + Other</title>
          <description>Alogliptin 25 mg, tablets, orally, once daily for up to 12 months in routine medical care. Participants in this group did not receive an α-GI within 3 months from the start of administration of alogliptin or during the treatment period of alogliptin.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1560"/>
            <count group_id="B2" value="669"/>
            <count group_id="B3" value="989"/>
            <count group_id="B4" value="3218"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.0" spread="12.28"/>
                    <measurement group_id="B2" value="67.1" spread="12.13"/>
                    <measurement group_id="B3" value="64.0" spread="12.57"/>
                    <measurement group_id="B4" value="65.1" spread="12.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="640"/>
                    <measurement group_id="B2" value="286"/>
                    <measurement group_id="B3" value="438"/>
                    <measurement group_id="B4" value="1364"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="920"/>
                    <measurement group_id="B2" value="383"/>
                    <measurement group_id="B3" value="551"/>
                    <measurement group_id="B4" value="1854"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <description>All participants were enrolled in Japan.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Japan</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1560"/>
                    <measurement group_id="B2" value="669"/>
                    <measurement group_id="B3" value="989"/>
                    <measurement group_id="B4" value="3218"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Time From Diagnosis of Type 2 Diabetes</title>
          <population>The number analyzed is the number of participants with data available for analysis.</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1161"/>
                    <count group_id="B2" value="501"/>
                    <count group_id="B3" value="722"/>
                    <count group_id="B4" value="2384"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.45" spread="4.923"/>
                    <measurement group_id="B2" value="8.10" spread="7.018"/>
                    <measurement group_id="B3" value="5.03" spread="5.732"/>
                    <measurement group_id="B4" value="4.91" spread="5.937"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <population>The number analyzed is the number of participants with data available for analysis.</population>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1439"/>
                    <count group_id="B2" value="621"/>
                    <count group_id="B3" value="894"/>
                    <count group_id="B4" value="2954"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="160.22" spread="9.686"/>
                    <measurement group_id="B2" value="159.33" spread="9.535"/>
                    <measurement group_id="B3" value="160.18" spread="9.738"/>
                    <measurement group_id="B4" value="160.02" spread="9.674"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Weight</title>
          <population>The number analyzed is the number of participants with data available for analysis.</population>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1538"/>
                    <count group_id="B2" value="664"/>
                    <count group_id="B3" value="976"/>
                    <count group_id="B4" value="3178"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.49" spread="13.699"/>
                    <measurement group_id="B2" value="62.68" spread="13.005"/>
                    <measurement group_id="B3" value="64.51" spread="14.046"/>
                    <measurement group_id="B4" value="64.12" spread="13.681"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <description>Body Mass Index = weight (kg)/[height (m)^2]</description>
          <population>The number analyzed is the number of participants with data available for analysis.</population>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1431"/>
                    <count group_id="B2" value="619"/>
                    <count group_id="B3" value="889"/>
                    <count group_id="B4" value="2939"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25.00" spread="4.225"/>
                    <measurement group_id="B2" value="24.52" spread="4.277"/>
                    <measurement group_id="B3" value="25.04" spread="4.190"/>
                    <measurement group_id="B4" value="24.91" spread="4.229"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Waist Circumference (Male)</title>
          <population>This baseline characteristic was analyzed only in male participants.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="920"/>
                    <count group_id="B2" value="383"/>
                    <count group_id="B3" value="551"/>
                    <count group_id="B4" value="1854"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt; 85cm</title>
                  <measurement_list>
                    <measurement group_id="B1" value="96"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="61"/>
                    <measurement group_id="B4" value="212"/>
                  </measurement_list>
                </category>
                <category>
                  <title>≥ 85cm</title>
                  <measurement_list>
                    <measurement group_id="B1" value="211"/>
                    <measurement group_id="B2" value="80"/>
                    <measurement group_id="B3" value="120"/>
                    <measurement group_id="B4" value="411"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="613"/>
                    <measurement group_id="B2" value="248"/>
                    <measurement group_id="B3" value="370"/>
                    <measurement group_id="B4" value="1231"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Waist Circumference (Female)</title>
          <population>This baseline characteristic was analyzed only in female participants.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="640"/>
                    <count group_id="B2" value="286"/>
                    <count group_id="B3" value="438"/>
                    <count group_id="B4" value="1364"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt; 90cm</title>
                  <measurement_list>
                    <measurement group_id="B1" value="152"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="85"/>
                    <measurement group_id="B4" value="302"/>
                  </measurement_list>
                </category>
                <category>
                  <title>≥ 90cm</title>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="52"/>
                    <measurement group_id="B4" value="159"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="418"/>
                    <measurement group_id="B2" value="184"/>
                    <measurement group_id="B3" value="301"/>
                    <measurement group_id="B4" value="903"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Healthcare category</title>
          <description>Participants were categorized as outpatient, inpatient, and In- to/from out-patient (participants who were both outpatient and inpatient at any time prior to enrollment).</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Out-patient</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1524"/>
                    <measurement group_id="B2" value="640"/>
                    <measurement group_id="B3" value="942"/>
                    <measurement group_id="B4" value="3106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>In-patient</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>In- to/from out-patient</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="36"/>
                    <measurement group_id="B4" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pregnancy Status</title>
          <population>This baseline characteristic was analyzed only in female participants.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="640"/>
                    <count group_id="B2" value="286"/>
                    <count group_id="B3" value="438"/>
                    <count group_id="B4" value="1364"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Not pregnant</title>
                  <measurement_list>
                    <measurement group_id="B1" value="640"/>
                    <measurement group_id="B2" value="286"/>
                    <measurement group_id="B3" value="438"/>
                    <measurement group_id="B4" value="1364"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Pregnant</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of Allergy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Had no history of Allergy</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1377"/>
                    <measurement group_id="B2" value="583"/>
                    <measurement group_id="B3" value="856"/>
                    <measurement group_id="B4" value="2816"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Had history of Allergy</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="127"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="104"/>
                    <measurement group_id="B4" value="288"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="29"/>
                    <measurement group_id="B4" value="114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Complications</title>
          <description>Complications defined as a disease or a health condition for each participant at the start of study. Complications were classified as congenital anomalies, endocrine disorders, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, gastrointestinal (GI) disorders, renal disease and other complications. Other complications included all complications except for those mentioned above.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Had No Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="314"/>
                    <measurement group_id="B2" value="61"/>
                    <measurement group_id="B3" value="103"/>
                    <measurement group_id="B4" value="478"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Had Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1246"/>
                    <measurement group_id="B2" value="608"/>
                    <measurement group_id="B3" value="886"/>
                    <measurement group_id="B4" value="2740"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetic Complications</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Had No Diabetic Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1402"/>
                    <measurement group_id="B2" value="506"/>
                    <measurement group_id="B3" value="831"/>
                    <measurement group_id="B4" value="2739"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Had Diabetic Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="158"/>
                    <measurement group_id="B2" value="163"/>
                    <measurement group_id="B3" value="158"/>
                    <measurement group_id="B4" value="479"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hypertension Complications</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Had No Hypertension Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="676"/>
                    <measurement group_id="B2" value="249"/>
                    <measurement group_id="B3" value="383"/>
                    <measurement group_id="B4" value="1308"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Had Hypertension Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="884"/>
                    <measurement group_id="B2" value="420"/>
                    <measurement group_id="B3" value="606"/>
                    <measurement group_id="B4" value="1910"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hyperlipidemia Complications</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Had No Hyperlipidemia Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="715"/>
                    <measurement group_id="B2" value="246"/>
                    <measurement group_id="B3" value="375"/>
                    <measurement group_id="B4" value="1336"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Had Hyperlipidemia Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="845"/>
                    <measurement group_id="B2" value="423"/>
                    <measurement group_id="B3" value="614"/>
                    <measurement group_id="B4" value="1882"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hyperuricemia Complications</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Had No Hyperuricemia Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1411"/>
                    <measurement group_id="B2" value="611"/>
                    <measurement group_id="B3" value="891"/>
                    <measurement group_id="B4" value="2913"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Had Hyperuricemia Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="149"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="98"/>
                    <measurement group_id="B4" value="305"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hepatic Dysfunction Complications</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Had No Hepatic Dysfunction Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1322"/>
                    <measurement group_id="B2" value="553"/>
                    <measurement group_id="B3" value="799"/>
                    <measurement group_id="B4" value="2674"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Had Hepatic Dysfunction Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="238"/>
                    <measurement group_id="B2" value="116"/>
                    <measurement group_id="B3" value="190"/>
                    <measurement group_id="B4" value="544"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Degree of Hepatic Dysfunction</title>
          <description>Severity was determined using aspartate aminotransferase (AST) or alanine transaminase (ALT) values at the start of treatment with alogliptin. For the assessment of severity, the following categories were used and higher grades of serum AST or ALT were adopted. Normal: &lt;50 international units per liter (IU/L) Grade 1: &gt;=50 to &lt;100 IU/L Grade 2: &gt;=100 to &lt;500 IU/L Grade 3: &gt;=500 IU/L</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Normal</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="986"/>
                    <measurement group_id="B2" value="443"/>
                    <measurement group_id="B3" value="596"/>
                    <measurement group_id="B4" value="2025"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="122"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="87"/>
                    <measurement group_id="B4" value="245"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="430"/>
                    <measurement group_id="B2" value="180"/>
                    <measurement group_id="B3" value="287"/>
                    <measurement group_id="B4" value="897"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Renal Dysfunction Complications</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Had No Renal Dysfunction Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1427"/>
                    <measurement group_id="B2" value="563"/>
                    <measurement group_id="B3" value="861"/>
                    <measurement group_id="B4" value="2851"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Had Renal Dysfunction Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="133"/>
                    <measurement group_id="B2" value="106"/>
                    <measurement group_id="B3" value="128"/>
                    <measurement group_id="B4" value="367"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Degree of Renal Dysfunction (eGFR)</title>
          <description>Estimated glomerular filtration rate (eGFR) was calculated using variables of gender, age at the start of treatment, and serum creatinine values, and severity was determined based on the following categories. If the serum creatinine value at the start of treatment was not listed, the severity was reported as “unknown.” Normal: &gt;=90 milliliter per min (mL/min)/1.73^2, Mild: &gt;=60 mL/min/1.73^2 to &lt;90 mL/min/1.73^2, Moderate: &gt;=30 mL/min/1.73^2 to &lt;60 mL/min/1.73^2, Severe: &lt;30 mL/min/1.73^2 eGFR = 194 * Cr^-1.094 * (age)^-0.287 (* 0.739 if female) where Cr is creatinine value.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Normal</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="249"/>
                    <measurement group_id="B2" value="108"/>
                    <measurement group_id="B3" value="189"/>
                    <measurement group_id="B4" value="546"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mild</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="667"/>
                    <measurement group_id="B2" value="254"/>
                    <measurement group_id="B3" value="361"/>
                    <measurement group_id="B4" value="1282"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="190"/>
                    <measurement group_id="B2" value="108"/>
                    <measurement group_id="B3" value="121"/>
                    <measurement group_id="B4" value="419"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Severe</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="426"/>
                    <measurement group_id="B2" value="177"/>
                    <measurement group_id="B3" value="293"/>
                    <measurement group_id="B4" value="896"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Degree of Renal Dysfunction (Cr)</title>
          <description>Normal or Mild: =&lt; 1.4 mg/dL (for male) or =&lt; 1.2 mg/dL (for female), Moderate: &gt;1.4 mg/dL to =&lt; 2.4 mg/dL (for male) or &gt;1.2 mg/dL to =&lt; 2.0 mg/dL (for female), Severe: &gt; 2.4 mg/dL (for male), &gt; 2.0 mg/dL (for female). If the serum creatinine value (Cr) at the start of treatment was not listed, the severity was reported as “unknown.”</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Normal or Mild</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1089"/>
                    <measurement group_id="B2" value="466"/>
                    <measurement group_id="B3" value="664"/>
                    <measurement group_id="B4" value="2219"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Severe</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="426"/>
                    <measurement group_id="B2" value="177"/>
                    <measurement group_id="B3" value="293"/>
                    <measurement group_id="B4" value="896"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cardiac Disease Complications</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Had No Cardiac Disease Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1417"/>
                    <measurement group_id="B2" value="578"/>
                    <measurement group_id="B3" value="870"/>
                    <measurement group_id="B4" value="2865"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Had Cardiac Disease Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="143"/>
                    <measurement group_id="B2" value="91"/>
                    <measurement group_id="B3" value="119"/>
                    <measurement group_id="B4" value="353"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Heart Failure Complications</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Had No Heart Failure Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1517"/>
                    <measurement group_id="B2" value="649"/>
                    <measurement group_id="B3" value="970"/>
                    <measurement group_id="B4" value="3136"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Had Heart Failure Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>New York Heart Association (NYHA) Heart Failure Classification</title>
          <description>NYHA functional classification ranges from Class I (Participants with cardiac disease but without resulting limitations of physical activity), Class II (Participants with cardiac disease resulting in slight limitation of physical activity), Class III (Participants with cardiac disease resulting in marked limitation of physical activity), Class IV (Participants with cardiac disease resulting in inability to carry on any physical activity without discomfort).</description>
          <population>This baseline characteristic was analyzed only for Participants who had complications of heart failure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="43"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="19"/>
                    <count group_id="B4" value="82"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>NYHA Class I</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>NYHA Class II</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>NYHA Class III</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>NYHA Class IV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Stroke-Related Disorder Complications</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Had No Stroke-Related Disorder Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1505"/>
                    <measurement group_id="B2" value="613"/>
                    <measurement group_id="B3" value="922"/>
                    <measurement group_id="B4" value="3040"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Had Stroke-Related Disorder Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="67"/>
                    <measurement group_id="B4" value="178"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Allergic Disease Complications</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Had No Allergic Disease Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1466"/>
                    <measurement group_id="B2" value="627"/>
                    <measurement group_id="B3" value="914"/>
                    <measurement group_id="B4" value="3007"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Had Allergic Disease Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="94"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="75"/>
                    <measurement group_id="B4" value="211"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Malignancy Complications</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Had No Malignancy Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1543"/>
                    <measurement group_id="B2" value="661"/>
                    <measurement group_id="B3" value="960"/>
                    <measurement group_id="B4" value="3164"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Had Malignancy Complications</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="29"/>
                    <measurement group_id="B4" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Medical history</title>
          <description>Medical history defined as a disease or a health condition for each participant before start of the study. Medical history was classified as congenital anomalies, hematologic disorders, psychiatric and nervous system disorders, cardiovascular disorders, respiratory disorders, GI disorders, hepatic and biliary disorders, renal disease and other medical history. Other medical history included all medical history except for those mentioned above.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Had No Medical History</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1255"/>
                    <measurement group_id="B2" value="501"/>
                    <measurement group_id="B3" value="768"/>
                    <measurement group_id="B4" value="2524"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Had Medical History</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="225"/>
                    <measurement group_id="B2" value="126"/>
                    <measurement group_id="B3" value="166"/>
                    <measurement group_id="B4" value="517"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="55"/>
                    <measurement group_id="B4" value="177"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Alcohol Consumption Classification</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Drinking Almost Everyday</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="412"/>
                    <measurement group_id="B2" value="158"/>
                    <measurement group_id="B3" value="276"/>
                    <measurement group_id="B4" value="846"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Drinking Almost Everyday</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="891"/>
                    <measurement group_id="B2" value="383"/>
                    <measurement group_id="B3" value="526"/>
                    <measurement group_id="B4" value="1800"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="257"/>
                    <measurement group_id="B2" value="128"/>
                    <measurement group_id="B3" value="187"/>
                    <measurement group_id="B4" value="572"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Smoking Classification</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Never Smoked</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="737"/>
                    <measurement group_id="B2" value="292"/>
                    <measurement group_id="B3" value="414"/>
                    <measurement group_id="B4" value="1443"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Current Smoker</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="227"/>
                    <measurement group_id="B2" value="77"/>
                    <measurement group_id="B3" value="155"/>
                    <measurement group_id="B4" value="459"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ex-Smoker</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="249"/>
                    <measurement group_id="B2" value="153"/>
                    <measurement group_id="B3" value="160"/>
                    <measurement group_id="B4" value="562"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="347"/>
                    <measurement group_id="B2" value="147"/>
                    <measurement group_id="B3" value="260"/>
                    <measurement group_id="B4" value="754"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Glycosylated Hemoglobin A1c (HbA1c)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>HbA1c &lt;6.0 percent</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="33"/>
                    <measurement group_id="B4" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HbA1c &gt;=6.0 to &lt;7.0 percent</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="475"/>
                    <measurement group_id="B2" value="134"/>
                    <measurement group_id="B3" value="195"/>
                    <measurement group_id="B4" value="804"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HbA1c &gt;=7.0 to &lt;8.0 percent</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="576"/>
                    <measurement group_id="B2" value="270"/>
                    <measurement group_id="B3" value="320"/>
                    <measurement group_id="B4" value="1166"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HbA1c &gt;=8.0 percent</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="351"/>
                    <measurement group_id="B2" value="195"/>
                    <measurement group_id="B3" value="345"/>
                    <measurement group_id="B4" value="891"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1560"/>
                    <count group_id="B2" value="669"/>
                    <count group_id="B3" value="989"/>
                    <count group_id="B4" value="3218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="130"/>
                    <measurement group_id="B2" value="46"/>
                    <measurement group_id="B3" value="96"/>
                    <measurement group_id="B4" value="272"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Experience at Least One Adverse Events</title>
        <time_frame>Up to Month 36</time_frame>
        <population>Safety Analysis Set was defined as all participants who were enrolled and completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Alogliptin</title>
            <description>Alogliptin 25 mg, tablets, orally, once daily for up to 36 months in routine medical care. Participants in this group received no diabetic drugs within 3 months from the start of administration of alogliptin and during the treatment period of alogliptin.</description>
          </group>
          <group group_id="O2">
            <title>Alogliptin + α-GI</title>
            <description>Alogliptin 25 mg, tablets, orally, once daily for up to 36 months in routine medical care. Participants in this group received an α-GI within 3 months from the start of administration of alogliptin and during the treatment period of alogliptin.</description>
          </group>
          <group group_id="O3">
            <title>Alogliptin + Other</title>
            <description>Alogliptin 25 mg, tablets, orally, once daily for up to 12 months in routine medical care. Participants in this group did not receive an α-GI within 3 months from the start of administration of alogliptin or during the treatment period of alogliptin.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Experience at Least One Adverse Events</title>
          <population>Safety Analysis Set was defined as all participants who were enrolled and completed the study.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1560"/>
                <count group_id="O2" value="669"/>
                <count group_id="O3" value="989"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="151"/>
                    <measurement group_id="O2" value="98"/>
                    <measurement group_id="O3" value="139"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Glycosylated Hemoglobin (HbA1c)</title>
        <description>The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at month 36 relative to baseline.</description>
        <time_frame>Baseline, Months 1, 3, 6, 12, 18, 24, 30, 36 and final assessment (up to Month 36)</time_frame>
        <population>The efficacy assessment population was defined as participants who completed the study and had available efficacy data at baseline and post baseline. Reported group were Alogliptin and Alogliptin + α-GI and data for Alogliptin + Other were not collected as specified in protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Alogliptin</title>
            <description>Alogliptin 25 mg, tablets, orally, once daily for up to 36 months in routine medical care. Participants in this group received no diabetic drugs within 3 months from the start of administration of alogliptin and during the treatment period of alogliptin.</description>
          </group>
          <group group_id="O2">
            <title>Alogliptin + α-GI</title>
            <description>Alogliptin 25 mg, tablets, orally, once daily for up to 36 months in routine medical care. Participants in this group received an α-GI within 3 months from the start of administration of alogliptin and during the treatment period of alogliptin.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Glycosylated Hemoglobin (HbA1c)</title>
          <description>The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at month 36 relative to baseline.</description>
          <population>The efficacy assessment population was defined as participants who completed the study and had available efficacy data at baseline and post baseline. Reported group were Alogliptin and Alogliptin + α-GI and data for Alogliptin + Other were not collected as specified in protocol.</population>
          <units>Percent</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1341"/>
                <count group_id="O2" value="612"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change at Month 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1015"/>
                    <count group_id="O2" value="504"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.45" spread="0.581"/>
                    <measurement group_id="O2" value="-0.33" spread="0.708"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1104"/>
                    <count group_id="O2" value="535"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.79" spread="1.007"/>
                    <measurement group_id="O2" value="-0.54" spread="1.074"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1043"/>
                    <count group_id="O2" value="526"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.84" spread="1.045"/>
                    <measurement group_id="O2" value="-0.70" spread="1.128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1030"/>
                    <count group_id="O2" value="498"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.83" spread="1.102"/>
                    <measurement group_id="O2" value="-0.75" spread="1.054"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="805"/>
                    <count group_id="O2" value="423"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.81" spread="1.077"/>
                    <measurement group_id="O2" value="-0.62" spread="1.190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="753"/>
                    <count group_id="O2" value="394"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.82" spread="1.095"/>
                    <measurement group_id="O2" value="-0.66" spread="1.214"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="664"/>
                    <count group_id="O2" value="353"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.83" spread="1.114"/>
                    <measurement group_id="O2" value="-0.73" spread="1.271"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="663"/>
                    <count group_id="O2" value="331"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.84" spread="1.131"/>
                    <measurement group_id="O2" value="-0.72" spread="1.318"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Final Assessment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1341"/>
                    <count group_id="O2" value="612"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.81" spread="1.140"/>
                    <measurement group_id="O2" value="-0.63" spread="1.381"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Fasting Blood Glucose</title>
        <description>The change in the value of fasting blood glucose collected at month 36 relative to baseline.</description>
        <time_frame>Baseline, Months 1, 3, 6, 12, 18, 24, 30, 36 and final assessment (up to Month 36)</time_frame>
        <population>The efficacy assessment population was defined as participants who completed the study and had available efficacy data at baseline and post baseline. Reported group were Alogliptin and Alogliptin + α-GI and data for Alogliptin + Other were not collected as specified in protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Alogliptin</title>
            <description>Alogliptin 25 mg, tablets, orally, once daily for up to 36 months in routine medical care. Participants in this group received no diabetic drugs within 3 months from the start of administration of alogliptin and during the treatment period of alogliptin.</description>
          </group>
          <group group_id="O2">
            <title>Alogliptin + α-GI</title>
            <description>Alogliptin 25 mg, tablets, orally, once daily for up to 36 months in routine medical care. Participants in this group received an α-GI within 3 months from the start of administration of alogliptin and during the treatment period of alogliptin.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Fasting Blood Glucose</title>
          <description>The change in the value of fasting blood glucose collected at month 36 relative to baseline.</description>
          <population>The efficacy assessment population was defined as participants who completed the study and had available efficacy data at baseline and post baseline. Reported group were Alogliptin and Alogliptin + α-GI and data for Alogliptin + Other were not collected as specified in protocol.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="510"/>
                <count group_id="O2" value="229"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change at Month 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="311"/>
                    <count group_id="O2" value="152"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-22.9" spread="45.05"/>
                    <measurement group_id="O2" value="-4.9" spread="41.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="358"/>
                    <count group_id="O2" value="175"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-21.7" spread="39.40"/>
                    <measurement group_id="O2" value="-8.3" spread="36.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="322"/>
                    <count group_id="O2" value="171"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-19.1" spread="36.46"/>
                    <measurement group_id="O2" value="-14.5" spread="49.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="324"/>
                    <count group_id="O2" value="163"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-23.1" spread="43.60"/>
                    <measurement group_id="O2" value="-18.4" spread="41.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="234"/>
                    <count group_id="O2" value="126"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-21.1" spread="41.54"/>
                    <measurement group_id="O2" value="-16.0" spread="46.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="119"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-19.9" spread="42.56"/>
                    <measurement group_id="O2" value="-14.0" spread="42.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="183"/>
                    <count group_id="O2" value="102"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-24.4" spread="39.14"/>
                    <measurement group_id="O2" value="-11.7" spread="52.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="201"/>
                    <count group_id="O2" value="99"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-23.0" spread="45.19"/>
                    <measurement group_id="O2" value="-18.6" spread="48.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Final Assessment</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="510"/>
                    <count group_id="O2" value="229"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-24.5" spread="48.45"/>
                    <measurement group_id="O2" value="-12.2" spread="51.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to Month 36</time_frame>
      <desc>Reported data on Serious Adverse Events were serious adverse drug reactions since only serious adverse drug reactions were collected in this study as specified protocol. Participants may be represented in more than 1 category.</desc>
      <group_list>
        <group group_id="E1">
          <title>Alogliptin</title>
          <description>Alogliptin 25 mg, tablets, orally, once daily for up to 36 months in routine medical care. Participants in this group received no diabetic drugs within 3 months from the start of administration of alogliptin and during the treatment period of alogliptin.</description>
        </group>
        <group group_id="E2">
          <title>Alogliptin + αGI</title>
          <description>Alogliptin 25 mg, tablets, orally, once daily for up to 36 months in routine medical care. Participants in this group received an α-GI within 3 months from the start of administration of alogliptin and during the treatment period of alogliptin.</description>
        </group>
        <group group_id="E3">
          <title>Alogliptin + Other</title>
          <description>Alogliptin 25 mg, tablets, orally, once daily for up to 12 months in routine medical care. Participants in this group did not receive an α-GI within 3 months from the start of administration of alogliptin or during the treatment period of alogliptin.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 19.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="989"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="989"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="989"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="989"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Sudden death</sub_title>
                <description>The reasons of events are not determined because assessment findings were insufficient to specify the reason.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="989"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <description>The reasons of events are not determined because assessment findings were insufficient to specify the reason.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="989"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="989"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="989"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="989"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="989"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Bile duct cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="989"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="989"/>
              </event>
              <event>
                <sub_title>Metastases to lymph nodes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="989"/>
              </event>
              <event>
                <sub_title>Lung neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="989"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="989"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="989"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0.4</frequency_threshold>
        <default_vocab>MedDRA 19.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="989"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="989"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="1560"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="669"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="989"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Medical Director</name_or_title>
      <organization>Takeda</organization>
      <phone>+1-877-825-3327</phone>
      <email>trialdisclosures@takeda.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

